These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24047970)

  • 1. Impact of late presentation on the risk of death among HIV-infected people in France (2003-2009).
    Montlahuc C; Guiguet M; Abgrall S; Daneluzzi V; de Salvador F; Launay O; Martinez V; Partisani M; Pradier C; Rouveix E; Valin N; Grabar S; Costagliola D;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):197-203. PubMed ID: 24047970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First presentation for care of HIV-infected patients with low CD4 cell count in Lyon, France: risk factors and consequences for survival.
    Touré A; Khanafer N; Baratin D; Bailly F; Livrozet JM; Trepo C; Peyramond D; Touraine JL; Vanhems P
    AIDS Care; 2012; 24(10):1272-6. PubMed ID: 22416893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.
    Raffetti E; Postorino MC; Castelli F; Casari S; Castelnuovo F; Maggiolo F; Di Filippo E; D'Avino A; Gori A; Ladisa N; Di Pietro M; Sighinolfi L; Zacchi F; Torti C
    BMC Public Health; 2016 Aug; 16(1):878. PubMed ID: 27557878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group - results from the ANRS-VESPA2 Study, France.
    Wilson Kd; Dray-Spira R; Aubrière C; Hamelin C; Spire B; Lert F;
    AIDS Care; 2014; 26 Suppl 1():S83-93. PubMed ID: 24731147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.
    Celesia BM; Castronuovo D; Pinzone MR; Bellissimo F; Mughini MT; Lupo G; Scarpino MR; Gussio M; Palermo F; Cosentino S; Cacopardo B; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2218-24. PubMed ID: 23893189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study.
    Guaraldi G; Zona S; Menozzi M; Brothers TD; Carli F; Stentarelli C; Dolci G; Santoro A; Da Silva AR; Rossi E; Falutz J; Mussini C
    AIDS Res Ther; 2017 Feb; 14(1):8. PubMed ID: 28209189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late presentation for HIV care in Southwest Ethiopia in 2003-2015: prevalence, trend, outcomes and risk factors.
    Gesesew HA; Ward P; Woldemichael K; Mwanri L
    BMC Infect Dis; 2018 Jan; 18(1):59. PubMed ID: 29378523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Rooney J; Meng TC; Fischl MA; Collier AC; Phair JP; Hirsch MS
    N Engl J Med; 1995 Aug; 333(7):401-7. PubMed ID: 7616988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and Operational Research: CD4 Count Monitoring Frequency and Risk of CD4 Count Dropping Below 200 Cells Per Cubic Millimeter Among Stable HIV-Infected Patients in New York City, 2007-2013.
    Myers JE; Xia Q; Torian LV; Irvine M; Harriman G; Sepkowitz KA; Shepard CW
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):e73-8. PubMed ID: 26536317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, determinants and consequences of delayed access to care for HIV infection in France.
    Lanoy E; Mary-Krause M; Tattevin P; Perbost I; Poizot-Martin I; Dupont C; Costagliola D;
    Antivir Ther; 2007; 12(1):89-96. PubMed ID: 17503752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rapid progressors in HIV infection as an extreme phenotype.
    Olson AD; Guiguet M; Zangerle R; Gill J; Perez-Hoyos S; Lodi S; Ghosn J; Dorrucci M; Johnson A; Sannes M; Moreno S; Porter K;
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):15-21. PubMed ID: 24872130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of Late Presentation to HIV care in a South Indian Cohort.
    Rao S; Av S; Unnikrishnan B; Madi D; Shetty AK
    Am J Trop Med Hyg; 2018 Nov; 99(5):1331-1335. PubMed ID: 30226140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
    Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
    Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
    Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS;
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
    Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
    Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in CD4 count among new enrollees in HIV care in the modern antiretroviral therapy era.
    Haines CF; Fleishman JA; Yehia BR; Berry SA; Moore RD; Bamford LP; Gebo KA;
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):84-90. PubMed ID: 24872131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection.
    Grabar S; Le Moing V; Goujard C; Egger M; Leport C; Kazatchkine MD; Weiss L; Costagliola D
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):284-92. PubMed ID: 15980687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.
    Rava M; Domínguez-Domínguez L; Bisbal O; López-Cortés LF; Busca C; Antela A; González-Ruano P; Hernández C; Iribarren JA; Rubio R; Moreno S; Jarrín I;
    PLoS One; 2021; 16(4):e0249864. PubMed ID: 33882093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.